Description: Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products. It also provides various therapeutic products, including anaesthetics; and injectable anticoagulants comprising orgaran for the treatment of HIT under the Thrombosis brand. In addition, the company offers oncology, endocrinology, and women's health products, as well as consumer healthcare products. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Home Page: www.aspenpharma.com
Aspen Place
Durban,
South Africa
Phone:
27 31 580 8600
Officers
| Name | Title |
|---|---|
| Mr. Stephen Bradley Saad | Group CEO & Exec. Director |
| Mr. Sean M. Capazorio | Group CFO & Exec. Director |
| Ms. Lorraine Hill | Group Chief Operations Officer & Responsible Pharmacist |
| Mr. Michael Guy Attridge B.Com., BCom, CA(SA) | Group Chief Advisor |
| Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corp. Services Officer |
| Ms. Zizipho Mmango | Group Chief Strategic Devel. Officer |
| Mr. Riaan Verster ACIS, BProc, L.L.B., L.L.M., LLB, LLM | Company Sec., Group Governance Officer & Group Compliance Officer |
| Mr. Trevor Julian Ziman | Regional Chief Exec. Officer of Asia Pacific |
| Mr. Stavros Nicolaou | Group Sr. Exec. of Strategic Trade |
| Mr. Carnie van der Linde | Group Commercial Head |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.8 |
| Price-to-Book MRQ: | 0.882 |
| Price-to-Sales TTM: | 0.091 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 8580 |